Bacillus Calmette-Guerin (BCG) and antigen presenting cells for treatment of bladder cancer
US12168048B2 · kind B2 · utility
0Cited by
5References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 16, 2024 |
| Grant date | Dec 17, 2024 |
| Priority date | — |
| Expiry date | May 16, 2044 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/585
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Combination therapeutics for the treatment of cancer include the use of immune effector cells, IL-15 based superagonists and one or more immunotherapeutic agents such as Bacillus Calmette-Guerin (BCG).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.